Multiple Sclerosis, Chronic Progressive Clinical Trial
— PIAOfficial title:
Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS
Verified date | May 2017 |
Source | Universitätsklinikum Hamburg-Eppendorf |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Due to their ubiquitary distribution, smartphones might serve as an easy way/ possibility to use feedback mechanism in an app-based intervention program to increase physical activity in Multiple Sclerosis (MS) patients. Internet based cognitive-behavioral interventions have been explored as effective in the last years. In addition, smartphone-based mobility assessment and intervention might be a promising approach in other MS types and for real-life mobility assessment in observational and interventional trials. The aim is to investigate the impact of a smartphone based information and feedback program on physical activity in a 3 months, randomised waiting-group controlled trial of 40 progressive MS patients.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | May 30, 2017 |
Est. primary completion date | May 30, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - progressive MS Exclusion Criteria: - other major health disorder - EDSS above 6 |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Universitätsklinikum Hamburg-Eppendorf |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of responders | Rate of responders as defined by a 20% increase of steps or 20% increase in physical activity as measured with the actigraph | 3 Months | |
Secondary | Physical activity: total activity | Physical activity and real-life mobility: 1-week accelerometry (actigraph) | 3 Months | |
Secondary | Physical activity: distance per day | Physical activity and real-life mobility: 1-week accelerometry (actigraph) | 3 Months | |
Secondary | Physical activity: number of steps per day | Physical activity and real-life mobility: 1-week accelerometry (actigraph) | 3 Months | |
Secondary | Questionnaires on quality of life (QoL, HAQUAMS) | Disease specific quality of life questionnaire | 3 Months | |
Secondary | Questionnaires on activities of daily living (ADL) | Frenchay activity index | 3 Months | |
Secondary | Questionnaires on physical activity | Godin Leisure time | 3 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Completed |
NCT01188811 -
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
|
Phase 2/Phase 3 | |
Recruiting |
NCT05562414 -
Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis
|
N/A | |
Completed |
NCT02545959 -
Intrathecal Rituximab in Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT01436838 -
China Betaferon Adherence, Coping and Nurse Support Study
|
N/A | |
Completed |
NCT03799718 -
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS
|
Phase 2 | |
Recruiting |
NCT00220493 -
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
|
Phase 1 | |
Recruiting |
NCT05496881 -
Exercise Effects in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT02903537 -
Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)
|
Phase 1 | |
Temporarily not available |
NCT02606929 -
Use of Well Known Drugs for New Destination - MS Improvement (MSNT)
|
Phase 0 | |
Completed |
NCT03424538 -
The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients
|
N/A | |
Completed |
NCT02403570 -
Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis
|
||
Active, not recruiting |
NCT04993274 -
Sensitivity of Motor Assessment in MS - a Prospective Cohort Study
|
||
Active, not recruiting |
NCT00411723 -
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
|
Phase 1 | |
Completed |
NCT00241254 -
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
|
Phase 3 | |
Completed |
NCT02632591 -
Use on Human Beings of Mix of Known Drugs for New Destination - MS Treatment
|
Phase 1 | |
Not yet recruiting |
NCT05385731 -
MUSCLE - Nordic Walking in MUltiple SCLErosis
|
N/A | |
Recruiting |
NCT05359653 -
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
|
Phase 1/Phase 2 | |
Completed |
NCT04550650 -
Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
|
N/A |